**Author details**

Jane Zveiter de Moraes1 \*, Barbara Hamaguchi1 , Camila Braggion1 , Enzo Speciale1 , Fernanda Cesar2 , Gabriela Soares1 , Juliana Osaki1 , Rodrigo Aguiar1 and Tauane Pereira1

1 Federal University of São Paulo, São Paulo, Brazil

2 São Camilo University Centre, São Paulo, Brazil

\*Address all correspondence to: janezvmo@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**35**

*Alternative Methods to Animal Use for Monoclonal Antibody Generation and Production*

and future perspectives. Int

10.1007/164\_2019\_323.

AID-0012-2013.

nbt1142.

Immunopharmacol. 2020;85:106639. doi:10.1016/j.intimp.2020.106639.

[9] Posner J, Barrington P, Brier T, Datta-Mannan A. Monoclonal Antibodies: Past, Present and Future. Handb Exp Pharmacol. 2019;260:81-141. doi:

[10] Stanfield RL, Wilson IA. Antibody Structure. Microbiol Spectr. 2014 Apr;2(2). doi: 10.1128/microbiolspec.

[11] Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol. 1987 Aug 20;196(4):901-917. doi: 10.1016/0022-2836(87)90412-8.

[12] Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol. 2005 Sep;23(9):1126-1136. doi: 10.1038/

[13] Gupta SK, Shukla P. Microbial platform technology for recombinant antibody fragment production: A review. Crit Rev Microbiol. 2017Feb;43(1):31-42. doi: 10.3109/1040841X.2016.1150959.

[14] Pothin E, Lesuisse D, Lafaye P. Brain Delivery of Single-Domain Antibodies:

Pharmaceutics. 2020 Sep 30;12(10):937. doi: 10.3390/pharmaceutics12100937.

A Focus on VHH and VNAR.

[15] Streltsov VA, Carmichael JA, Nuttall SD. Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype. Protein Sci. 2005 Nov;14(11):2901-9. doi: 10.1110/ps.051709505. Epub 2005 Sep 30. PMID: 16199666; PMCID:

[16] Ronca R, Benzoni P, De Luca A, Crescini E, Dell'era P. Phage displayed

PMC2253229.

*DOI: http://dx.doi.org/10.5772/intechopen.95485*

[1] Davis SL, Cheeke PR. Do domestic animals have minds and the ability to think? A provisional sample of opinions on the question. J Anim Sci. 1998 Aug;76(8):2072-2079. doi: 10.2527/1998.7682072x. PMID: 9734856.

[2] Purchase IF, Nedeva M. Editorial: Attitudes to alternatives to animal experimentation. Altern Lab Anim. 2002 May-Jun;30(3):351. doi: 10.1177/026119290203000313.

[3] Balls M. Replacement of animal procedures: alternatives in research, education and testing. Lab Anim. 1994 Jul;28(3):193-211. doi:

10.1258/002367794780681714. PMID:

[4] SBM. Sociedade Brasileira de Metrologia from: http://metrologia. org.br/wpsite/pan-main/ [accessed:

[5] AAVS. Research Alternatives - American Anti-Vivisection Society. Available from: https://aavs.org/ alternatives/research/ [Accessed:

[6] McArdle JE. The prohibition of routine ascites production of monoclonal antibodies in the United States: a successful application of the alternatives approach to

biomedical research. Altern Lab Anim. 2000 Sep-Oct;28(5):725-729. doi: 10.1177/026119290002800502.

[7] Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495-497.

[8] Parray HA, Shukla S, Samal S, et al. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement

doi: 10.1038/256495a0.

**References**

7967458.

2020-12-10]

2020-05-12]

*Alternative Methods to Animal Use for Monoclonal Antibody Generation and Production DOI: http://dx.doi.org/10.5772/intechopen.95485*
